#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Porphyria non-acute Small cell lung cancer limited stage Haemolytic uraemic syndrome Hyperchylomicronaemia Hereditary angioedema with C1 esterase inhibitor deficiency Metastatic malignant melanoma Follicular lymphoma stage I Insulinoma Factor IX deficiency Immune thrombocytopenia Glomerulonephritis minimal lesion Alternating hemiplegia of childhood Hepatitis B Oropharyngeal cancer recurrent Transitional cell carcinoma More trials…

    Learn about Rare Diseases

    Lymphangioma – Diagnostics Piriformis syndrome – Diagnostics Mucopolysaccharidosis III – Diagnostics Waldenstrom’s macroglobulinaemia – Life with Disease Lennox-Gastaut syndrome – Life with Disease Gaucher’s disease type I – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Amyotrophic lateral sclerosis – Diagnostics Ornithine transcarbamoylase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Menotrophin Gsk3858279 Cetrimide Ertapenem GSKVX000000034794 Ulipristal Acetate Interferon Alfa Methylone For-6219 Chloride Ion AZD5148 Tirbanibulin Odm-212 Ademetionine Abelacimab Ubamatamab Atezolizumab Avapritinib Biotin Bms-986408 More therapies…

    Learn about Your Condition

    Follicular lymphoma stage III Cough Nephrogenic anaemia Arginase deficiency Inflammation Mitochondrial myopathy Colon cancer stage II Vulvovaginal pain Mucopolysaccharidosis III Muscular dystrophy Diabetic ketoacidosis Porphyria non-acute Sciatica Leukocyte adhesion deficiency Hyperphagia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rbd5044 Sodium
    Poland Sweden

  • A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    Sweden

  • Study on Imaging Non-Small Cell Lung Cancer Using 68GaNOTA-Anti-MMR VHH2 in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N’,N”-Triacetic Acid, Labelled With Gallium Ga-68
    Belgium

  • Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Darolutamide
    • Docetaxel
    The Netherlands

  • Study on the Use of OTL-103 Gene Therapy and Drug Combination for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Immunodeficiency
    Investigated Drugs:
    • Etuvetidigene Autotemcel
    • Lenograstim
    • Plerixafor
    Italy

  • Evaluation of Two Prednisolone Treatment Strategies for Newly Diagnosed, Untreated Rheumatoid Arthritis Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Prednisolone
    Sweden
Previous Page
1 … 629 630 631 632 633 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!